Brain Cancer Clinical Trials

Clinical Trial: Safety Study of Intracerebral Topotecan for Recurrent Brain Tumors

Clinical Trial: Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor

Cervical Cancer Clinical Trials

Clinical Trial: Distribution of Human Papillomavirus (HPV) Genotypes in Patients With Cervical Cancer From Croatia (HPV-cancer)

Clinical Trial: Radical Trachelectomy for Cervical Cancer

Gastrointestinal Cancer Clinical Trials

Clinical Trial: Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer

Clinical Trial: The Effect of Chemotherapy and Surgery for Cancer on Exercise Capacity

Gynecologic Cancer Clinical Trials

Clinical Trial: Female Cancer Patients' Preference For Sexual Health Interventions

Clinical Trial: Ultrasound Hyperthermia Therapy After Implant Radiation Therapy in Treating Patients With Urinary Tract Cancer, Gynecologic Cancer, or Head and Neck Cancer

Kidney Cancer Clinical Trials

Clinical Trial: VEGF Trap in Treating Patients With Metastatic or Unresectable Kidney Cancer

Clinical Trial: Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Liver Cancer Clinical Trials

Clinical Trial: Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Clinical Trial: Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer

Lymphoma Clinical Trials

Clinical Trial: Temsirolimus, Bendamustine and Rituximab for Relapsed Follicular Lymphoma or Mantle Cell Lymphoma

Clinical Trial: Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma

Multiple Myeloma Clinical Trials

Clinical Trial: Phase 3, Randomized, Open Label Trial of Lenalidomide/Dexamethasone With or Without Elotuzumab in Relapsed or Refractory Multiple Myeloma (ELOQUENT - 2)

Clinical Trial: Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma (ELOQUENT - 1)

Pancreatic Cancer Clinical trials

Clinical Trial: Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery

Clinical Trial: Early Increase in Blood Flow (EIBS) in the Duodenum in Patients With Pancreatic Cancer

Sarcoma Clinical Trials

Clinical Trial: Preoperative Proton Radiotherapy for Retroperitoneal Sarcoma (SA03)

Clinical Trial: Treatment of Patients With RAD001 Who Have Progressive Sarcoma

Breast Cancer Clinical Trials

Clinical Trial: MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer

Clinical Trial: Pre-Surgery Positron Emission Mammography in Patients With Newly Diagnosed Breast Cancer

Colorectal Cancer Clinical Trials

Clinical Trial: Innovative Tools to Improve Colorectal Cancer Screening Rates in Manitoba

Clinical Trial: Colorectal Cancer Detection by Means of Optical Fluoroscopy

Genitourinary Cancer Clinical Trials

Clinical Trial: Atkins Diet and Prostate Cancer Clinical Trial

Clinical Trial: Patient Empowerment and Risk-assessed Treatment to Improve Outcome in the Elderly After Onco-surgery.

Head and Neck Cancer Clinical Trials

Clinical Trial: Impact of Secondary Lymphedema on Symptoms, Functional Status, and Quality of Life After Treatment in Patients With Head and Neck Cancer

Clinical Trial: Phase I Trial of Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers

Leukemia Clinical Trials

Clinical Trial: EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)

Clinical Trial: Direct Measurement of Leukemic Cell Turnover (Synthesis and Removal) in Patients With Chronic Lymphocytic Leukemia (CLL) Using Deuterated Water

Lung Cancer Clinical Trials

Clinical Trial: Study Comparing EBUS & EUS to Mediastinoscopy in Staging and Detection of Lung Cancer

Clinical Trial: Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable Non-Small Cell Lung Cancer (NSCLC) or Metastatic Lung Tumours

Melanoma Clinical Trials

Clinical Trial: Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma

Clinical Trial: Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells

Ovarian Cancer Clinical Trials

Clinical Trial: Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemotherapy for Advanced Ovarian Cancer

Clinical Trial: Data Collection for Patients With Low Grade Ovarian Carcinoma

Prostate Cancer Clinical Trials

Clinical Trial: Impact of F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in the Management of Primary and Recurrent Prostate Cancer

Clinical Trial: MR Image Guided Therapy in Prostate Cancer

Skin Cancer Clinical Trials

Clinical Trial: Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia

Clinical Trial: Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer

Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions